Trends and Inequities in Prescribing Semaglutide and Tirzepatide for Obesity in the US
In recent years, the introduction of novel pharmacotherapies such as semaglutide and tirzepatide has marked a transformative era in the ...
In recent years, the introduction of novel pharmacotherapies such as semaglutide and tirzepatide has marked a transformative era in the ...
In the ongoing battle against the global obesity epidemic, a particularly vulnerable group has often been overlooked: children and adolescents ...
Emerging data from new research is set to capture attention at the forthcoming European Congress on Obesity (ECO 2025) in ...
Recent research published in JAMA Network Open highlights pivotal trends affecting access to semaglutide, a groundbreaking glucagon-like peptide-1 (GLP-1) receptor ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine